Treatment and prognosis in peptic ulcer bleeding

Danish Medical Journal

Volumn 61, Issue 2, 2014, Pages

  Laursen, Stig Borbjerg ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE;

ARTICLE; ARTIFICIAL EMBOLISM; BLOOD TRANSFUSION; CHARLSON COMORBIDITY INDEX; FALL RISK ASSESSMENT; GASTROINTESTINAL ENDOSCOPY; HAZARD RATIO; HELICOBACTER INFECTION; HEMOSTASIS; HUMAN; LIFE SUSTAINING TREATMENT; MORTALITY; PEPTIC ULCER BLEEDING; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RESUSCITATION; RISK FACTOR; SCORING SYSTEM; SYSTEMATIC REVIEW; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DENMARK; EPIDEMIOLOGY; FEMALE; MALE; PEPTIC ULCER HEMORRHAGE; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ADULT; AGED; CONTROLLED CLINICAL TRIAL; HEALTH STATUS INDICATOR; METHODOLOGY; MIDDLE AGED; RECURRENT DISEASE; VALIDATION STUDY; VERY ELDERLY;

BLOOD TRANSFUSION; DECISION SUPPORT TECHNIQUES; DENMARK; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; MALE; PEPTIC ULCER HEMORRHAGE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ADULT; AGED; AGED, 80 AND OVER; HEALTH STATUS INDICATORS; HEMOSTASIS, ENDOSCOPIC; MIDDLE AGED; RECURRENCE; RISK FACTORS;

EID: 84895175642     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Article

References (142)

1. https://www.sundhed.dk/content/cms/63/4663_nationalarsrapport-akut-mave-tarm-kirurgi-2011_161211_final.pdf (Assessed august 2011)
2. Chinn AB, Littell AS, Badger GF, et al. Acute hemorrhage from peptic ulcer; a follow-up study of 310 patients. N Engl J Med 1956;255:973-8.
3. Philip J van der Eijk. Diocles of carystus-a collection of the fragments with translation and commentary. Brill 2000.
4. Ogilvie H. A hundred years of gastric surgery. Ann R Coll Surg Engl 1947;1:37-50.
5. Donatus M. De medica historia libri VI. Mantua, F. Osana 1586.
6. Barry Marshall. Helicobacter Pioneers: Firsthand Accounts from the Scientists Who Discovered Helicobacters 1892-1982. Wiley-Blackwell 2002.
7. Cruveilhier J. Anatomie pathologique du corps human. Paris. JB Balliere. 1829-1835.
8. Bierer DW. Bismuth subsalicylate: history, chemistry, and safety. Rev Infect Dis 1990; 12 Suppl 1:3-8.
9. Abercrombie J. Pathological and practical researches on disease of the stomach, the intestinal canal, the liver and other viscera of the abdomen. Edinburgh. Waugh and Innes 1828.
10. Prout W. On the nature of the acid and saline matters usually existing in the stomachs of animals. Phil Trans R Soc. London 1824.
11. Johnson J. An essay on indigestion. Philadelphia 1831.
12. Bonnevie O. Developments in the treatment of peptic ulcer. Scand J Gastroenterol 1987;127:51-4.
13. Boas I. Diagnostik und Therapie der Magenkrankheiten. Georg Thieme Verlag. Leipzig 1893.
14. Sippy BW. Gastric and duodenal ulcer. Medical cure by an efficient removal of gastric juice corrosion. JAMA 1915;64:1625-1630.
15. Meulengracht E. Treatment of haematemesis and melaena with food. Lancet 1935;2:1220-2.
16. Donahue PE. Parietal cell vagotomy versus vagotomyantrectomy: ulcer surgery in the modern era. World J Surg 2000;24:264-9.
17. Weil PH, Buchberger R. From Billroth to PCV: a century of gastric surgery. World J Surg 1999;23:736-742.
18. Finney JMT. The surgery of gastric and duodenal ulcer. Bull N Y Acad Med 1926;2:546-579.
19. Tanner NC, Desmond AM. The surgical treatment of haematemesis and melaena. Postgrad Med J 1950;26:253-66.
20. Dragstedt LR. Vagotomy for gastroduodenal ulcer. Ann Surg 1945;122:973-989.
21. Herrington JL, Sawyers JL, Scott HW: A twenty-five years experience with vagotomy-antrectomy. Arch Surg 1973;106:469-474.
22. Amdrup E, Andersen D, Jensen HE. Parietal cell (highly selective or proximal gastric) vagotomy for peptic ulcer disease. World J Surg 1977;1:19-25.
23. Amdrup E, Hovendal CP, Jensen HE. Vagotomy. Scand J Gastroenterol 1996;216:16-9.
24. Brimblecombe RW, Duncan WA, Durant GJ, et al. The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br J Pharmacol 1975;53:435-6.
25. Lam SK. Antacids: the past, the present, and the future. Baillieres Clin Gastroenterol 1988;2:641-54.
26. Salas M, Ward A, Caro J. Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials. BMC Gastroenterol 2002;2:17.
27. Forte JG, Lee HC. Gastric adenosine triphosphatases: a review of their possible role in HCl secretion. Gastroenterology 1977;73:921-6.
28. Olbe L, Berglindh T, Elander B, et al. Properties of a new class of gastric acid inhibitors. Scand J Gastroenterol 1979;55:131-5.
29. Walan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989;320:69-75.
30. Langtry HD, Wilde MI. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs. Drugs 1998;56:447-86.
31. Gisbert JP, Gonzalez L, Calvet X, et al. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther 2001;15:917-26.
32. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006:CD002094.
33. Kidd M, Modlin IM. A century of Helicobacter pylori: paradigms lost-paradigms regained. Digestion 1998;59:1-15.
34. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273.
35. Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-1275.
36. Bazzoli F, Zagari RM, Fossi S, et al. Efficacy and tolerability of a short-term, low dose triple therapy for eradication of Helicobacter pylori. Gastroenterology 1993;104:A40.
37. Bazzoli F, Zagari RM, Fossi S, et al. Short term low dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-777.
38. Vestergard A, Bredahl K, Schaffalitzky de Muckadell OB, et al. Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid. Ugeskr Laeger 2009;171:235-9.
39. Bruhl W, Krentz K. Lehrbuch und Atlas der Gastroskopie. Georg Thieme Verlag. Stuttgart 1969.
40. Zajaczkowski T. Johann Anton von Mikulicz-Radecki (1850-1905)--a pioneer of gastroscopy and modern surgery: his credit to urology. World J Urol 2008;26:75-86.
41. Schindler R. Gastroscopy: The endoscopic study of gastric pathology. The university of Chicago Press. Chicago 1950.
42. Wood IJ, Doig RK, et al. Gastric biopsy; report on 55 biopsies using a new flexible gastric biopsy tube. Lancet 1949;1:18-21.
43. Hadley GD.The gastro-camera. Br Med J 1965;2:1209-12.
44. Hirschowitz BI, Balint JA, Fulton WF. Gastroduodenal endoscopy with the fiberscope--an analysis of 500 examinations. Surg Clin North Am 1962;42:1081-90.
45. Soehendra N, Werner B. New technique for endoscopic treatment of bleeding gastric ulcer. Endoscopy 1977;8:85-7.
46. Soehendra N, Grimm H, Stenzel M. Injection of nonvariceal bleeding lesions of the upper gastrointestinal tract. Endoscopy 1985;17:129-32.
47. Protell RL, Rubin CE, Auth DC, et al. The heater probe: a new endoscopic method for stopping massive gastrointestinal bleeding. Gastroenterology 1978;74:257-62.
48. Johnston JH, Jensen DM, Auth D. Experimental comparison of endoscopic yttrium-aluminum-garnet laser, electrosurgery, and heater probe for canine gut arterial coagulation. Importance of compression and avoidance of erosion. Gastroenterology 1987;92:1101-8.
49. Hayashi T, Yonezawa M, Kawabara T. The study on staunch clip for the treatment by endoscopy. Gastroenterol Endosc 1975;17:92-101.
50. Hachisu T. Evaluation of endoscopic hemostasis using an improved clipping apparatus. Surg Endosc 1988;2:13-7.
51. Laursen SB, Jorgensen HS, Schaffalitzky de Muckadell OB. Management of bleeding gastroduodenal ulcers. Dan Med J 2012;59:C4473.
52. Vergara M, Calvet X, Gisbert JP. Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers. Cochrane Database Syst Rev 2007;CD005584.
53. Barkun AN, Martel M, Toubouti Y, et al. Endoscopic haemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc 2009;69:786-99.
54. Marmo R, Rotondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a metaanalysis of controlled trials. Am J Gastroenterol 2007;102:279-289.
55. Saeed ZA, Winchester CB, Michaeletz PA, et al. A scoring system to predict rebleeding after endoscopic therapy of nonvariceal upper gastrointestinal hemorrhage. Am J Gastroenterol 1993;88:1842-9.
56. Longstreth GF, Feitelberg SP. Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series. Gastrointest Endosc 1998;47:219-22.
57. Rockall TA, Logan RFA, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316-21.
58. Hay JA, Lyubashewsky E, Elashoff J, et al. Upper gastrointestinal hemorrhage clinical guideline determining the optimal hospital length of stay. Am J Med 1996;100:313-22.
59. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper gastrointestinal haemorrhage. Lancet 2000;356:1318-21.
60. Cipolletta L, Bianco MA, Rotondano G, et al. Outpatient management for low-risk nonvariceal upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 2002;55:1-5.
61. Cameron EA, Pratap JN, Sims TJ, et al. Three year prospective validation of a pre-endoscopic risk stratification in patients with acute upper-gastrointestinal haemorrhage. Eur J Gastro Hepatol 2002;14:497-501.
62. Imperiale TF, Dominitz JA, Provencale DT, et al. Predicting poor outcome from acute upper gastrointestinal hemorrhage. Arch Intern Med 2007;167:1291-96.
63. Stanley AJ, Ashley D, Dalton HR, et al. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet 2009;373:42-7.
64. Hay JA, Maldonado L, Weingarten SR, et al. Prospective evaluation of a clinical guideline recommending hospital length of stay in upper gastrointestinal tract hemorrhage. JAMA 1997;278:2151-6.
65. Csillag C. Scoringssystem sender patienter med ovre gastrointestinal blodning hjem. Ugeskr Lager 2009;171:488.
66. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974;2:394-7.
67. Saeed ZA, Ramirez FC, Hepps KS, et al. Prospective validation of the Baylor bleeding score for predicting the likelihood of rebleeding after endoscopic hemostasis of peptic ulcers. Gastrointest Endosc 1995;41:561-5.
68. Longstreth GF, Feitelberg SP. Outpatient care of selected patients with acute non-variceal upper gastrointestinal haemorrhage. Lancet 1995;345:108-11.
69. Rockall TA, Logan RF, Devlin HB, et al. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet 1996;347:1138-40.
70. Silverstein FE, Gilbert DA, Tedesco FJ, et al. The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc 1981;27:80-93.
71. Blatchford O, Davidson LA, Murray WR, et al. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ 1997;315:510-4.
72. Stanley AJ, Dalton HR, Blatchford O, et al. Multicentre comparison of the Glasgow Blatchford and Rockall Scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage. Aliment Pharmacol Ther 2011;34:470-5.
73. Adamsen S, Norgaard B, Bendix J, et al. Rebleeding after endoscopic hemostasis for bleeding gastroduodenal ulcer. Patient characteristics and outcomes. A nationwide prospective study. Gastrointest Endosc 2006;63:AB147.
74. Garcia-Iglesias P, Villoria A, Suarez D, et al. Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer. Aliment Pharmacol Ther 2011;34:888-900.
75. Elmunzer BJ, Young SD, Inadomi JM, et al. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol 2008;103:2625-32.
76. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717-27.
77. Rosch J, Dotter CT, Brown MJ. Selective arterial embolization. A new method for control of acute gastrointestinal bleeding. Radiology 1972;102:303-306.
78. Loffroy R. Transcatheter arterial embolization should be the salvage treatment of choice in all patients with bleeding from duodenal ulcers resistant to endoscopic hemostasis. Scand J Gastroenterol 2010;45:1003-4.
79. Loffroy R, Rao P, Ota S, et al. Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol 2010;33:1088-100.
80. Andersen PE. Radiologic examination and endovascular treatment of acute upper gastrointestinal bleeding. Ugeskr Laeger 2007;69:591-3.
81. Aina R, Oliva V, Therasse E, et al. Arterial embolotherapy for upper gastrointestinal hemorrhage: outcome assessment. J Vasc Interv Radiol 2001;12:195-200.
82. Schenker M, Duszak R, Soulen M, et al. Upper gastrointestinal hemorrhage and transcatheter embolotherapy: clinical and technical factors impacting success and survival. J Vasc Interv Radiol 2001;12:1263-1271.
83. Eriksson LG, Sundbom M, Gustavsson S, et al. Endoscopic marking with a metallic clip facilitates transcatheter arterial embolization in upper peptic ulcer bleeding. J Vasc Interv Radiol 2006;17:959-964.
84. Eriksson LG, Ljungdahl M, Sundbom M, et al. Transcatheter arterial embolization versus surgery in the treatment of upper gastrointestinal bleeding after therapeutic endoscopy failure. J Vasc Interv Radiol 2008;19:1413-8.
85. Wong TC, Wong KT, Chiu PW, et al. A comparison of angiographic embolization with surgery after failed endoscopic hemostasis to bleeding peptic ulcers. Gastrointest Endosc 2011;73:900-8.
86. Ripoll C, Banares R, Beceiro I, et al. Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure. J Vasc Interv Radiol 2004;15:447-50.
87. Rorbaek-Madsen M, Fischer L, Thomsen H et al. Late outcome of bleeding gastric ulcer. Five to eight years' follow-up. Scand J Gastroenterol 1994;29:983-987.
88. Hudson N, Faulkner G, Smith SJ, et al. Late mortality in elderly patients surviving peptic ulcer bleeding. Gut 1995;37:177-181.
89. Kubba AK, Choudari C, Rajgopal C, et al. Reduced long-term survival following major peptic ulcer haemorrhage. Br J Surg 1997;84:265-8.
90. Hasselgren G, Carlsson J, Lind T, et al. Risk factors for rebleeding and fatal outcome in elderly patients with acute peptic ulcer bleeding. Eur J Gastroenterol Hepatol 1998;10:667-72.
91. Ruigomez A, Rodriguez LAG, Hasselgren G, et al. Overall mortality among patients surviving an episode of peptic ulcer bleeding. J Epidemiol Community Health 2000;54:130-133.
92. Wallis JP, Wells AW, Chapman CE. Changing indications for red cell transfusion from 2000 to 2004 in the North of England. Transfus Med 2006;16:411-7.
93. Hill GE, Frawley WH, Griffith KE, et al. Allogeneic Blood Transfusion Increases the Risk of Postoperative Bacterial Infection: A Meta-analysis. J Trauma 2003;54:908-14.
94. Landers DF, Hill GE, Wong KC, et al. Blood transfusion-induced immunomodulation. Anesth Analg 1996;82:187-204.
95. Engoren MC, Habib RH, Zacharias A, et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002;74:1180-6.
96. Kuduvalli M, Oo AY, Newall N, et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg 2005;27:592-8.
97. Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006;81:1650-7.
98. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-52.
99. Engoren M, Habib RH, Hadaway J, et al. The effect on longterm survival of erythrocyte transfusion given for cardiac valve operations. Ann Thorac Surg 2009;88:95-100.
100. Snell GD, Smith F, Fink MA. An enhancement of the growth of tumor homotransplants in mice produced by the intravenous injection of donor whole blood. Proc Am Assoc Cancer Res 1955;2:47.
101. Horimi T, Kagawa S, Ninomiya M, et al. Possible induction by blood transfusion of immunological tolerance against growth of transplanted tumors in mice. Acta Med Okayama 1983;37: 259-63.
102. Parrott NR, Lennard TW, Proud G. Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma. Ann R Coll Surg Engl 1990;72:77-81.
103. Francis DM, Shenton BK. Blood transfusion and tumor growth: evidence from laboratory animals. Lancet 1981;2:871.
104. Domasu S, Terada N, Sano H, et al. The effect of blood transfusion on immunological response in mice. Nippon Geka Gakkai Zasshi 1992;93:1-8.
105. Burstein HJ, Shea CM, Abbas AK. Aqueous antigens induce in vivo tolerance selectively in IL-2 and IFNy-producing (Thl) cells. J Immunol 1992;148:3687-91.
106. Lowry SF. Cytokine mediators of immunity and inflammation. Arch Surg 1993;128:1235-41.
107. Singh SK, Marquet RL, de Bruin RW. Consequences of blood loss on growth of artificial metastasis. Br J Surg 1988;75:377-9.
108. Parrott NR, Lennard TWJ, Taylor RMR, et al. Effect of perioperative blood transfusion on recurrence of colorectal cancer. Br J Surg 1986;73:970-3.
109. Blumberg N, Heal JM, Chuang C, et al. Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg 1988;207: 410-5.
110. Marsh J, Donnan PT, Hamer-Hodges DW. Association between transfusion with plasma and the recurrence of colorectal carcinoma. Br J Surg 1990;77:623-626.
111. Taha AS, McCloskey C, Craigen T, et al. Mortality following blood transfusion for non-variceal upper gastrointestinal bleeding. Frontline Gastroenterology 2011;2:218-225.
112. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
113. De Groot V, Beckerman H, Lankhorst GJ, et al. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 2003;56:221-9
114. WHO. Klassifikation af sygdomme. 8. revision. Sundhedsstyrelsen 1986
115. WHO. Klassifikation af sygdomme. 10. revision. Munksgaard 1992.
116. Stephens JR, Hare NC, Warshow U, et al. Management of minor upper gastrointestinal haemorrhage in the community using the Glasgow Blatchford Score. Eur J Gastroenterol Hepatol 2009;21:1340-6.
117. Hearnshaw SA, Logan RF, Lowe D, et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011;60:1327-35.
118. Zeitoun JD, Rosa-Hezode I, Chryssostalis A, et al. Epidemiology and adherence to guidelines on the management of bleeding peptic ulcer: A prospective multicenter observational study in 1140 patients. Clin Res Hepatol Gastroenterol 2012;36:227-234.
119. Bratanic A, Puljiz Z, Ljubicic N, et al. Predictive Factors of Rebleeding and Mortality Following Endoscopic Hemostasis in Bleeding Peptic Ulcers. Hepatogastroenterology 2012;60 doi: 10.5754/hge11838. [Epub ahead of print]
120. Cheng CL, Lin CH, Kuo CJ, et al. Predictors of rebleeding and mortality in patients with high-risk bleeding peptic ulcers. Dig Dis Sci 2010;55:2577-83.
121. Wong SK, Yu LM, Lau JY, et al. Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer. Gut 2002;50:322-5.
122. Vial JH, McLeod LJ, Roberts MS. Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawal. Adv Prostaglandin Thromboxane Leukot Res 1991;21A:157-160.
123. Beving H, Zhao C, Albage A, et al. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 1996;7:80-84.
124. Fatah K, Beving H, Albage A, et al. Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient? Eur Heart J 1996;17:1362-1366.
125. Collet JP, Himbet F, Steg PG. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 2000;76:257-258.
126. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004;110:2361-2367.
127. Albaladejo P, Geeraerts T, Francis F, et al. Aspirin withdrawal and acute lower limb ischemia. Anesth Analg. 2004;99:440-443.
128. Ferrari E, Benhamou M, Cerboni P, et al. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005;45:456-459.
129. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006;27:2667-2674.
130. Sung JJ, Lau JY, Ching JY, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 2010;152:1-9.
131. Bloom, SR, Ward, AS. Failure of secretin release in patients with duodenal ulcer. BMJ 1975;1:126-127.
132. Sasaki, H. Pathophysiology of peptic ulcer: Changes in serum secretin concentrations and the number of secretin cells in the duodenal mucosa. Nippon Shokakibyo Gakkai Zasshi 1985;82:1512-1519.
133. Deng X, Xiong X, Khomenko T, et al. Inappropriate angiogenic response as a novel mechanism of duodenal ulceration and impaired healing. Dig Dis Sci 2011;56:2792-801.
134. Camellini L, Merighi A, Pagnini C, et al. Comparison of three different risk scoring systems in non-variceal upper gastrointestinal bleeding. Dig Liver Dis 2004;36:271-7.
135. Kim BJ, Park MK, Kim SJ, et al. Comparison of scoring systems for the prediction of outcomes in patients with nonvariceal upper gastrointestinal bleeding: a prospective study. Dig Dis Sci 2009;54:2523-9.
136. Vreeburg EM, Terwee CB, Snel P, et al. Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut 1999;44:331-5.
137. Baradarian R, Ramdhaney S, Chapalamadugu R, et al. Early intensive resuscitation of patients with upper gastrointestinal bleeding decreases mortality. Am J Gastroenterol 2004;99:619-22.
138. Lim CH. Early intensive resuscitation of patients with upper gastrointestinal bleeding decreases mortality. Am J Gastroenterol 2004;99:2502-3.
139. Zittel TT, Jehle EC, Becker HD. Surgical management of peptic ulcer disease today--indication, technique and outcome. Langenbecks Arch Surg 2000;385:84-96.
140. Http://www.ClinicalTrails.gov (Identifier: NCT01125852) (Assessed August 2012)
141. Beckly DE, Casebow MP. Prediction of rebleeding from peptic ulcer experience with an endoscopic Doppler device. Gut 1986;27:96-9.
142. Kohler B, Maier M, Benz C, et al. Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy. Dig Dis Sci 1997;42:1370-4.